Uromigos Live-Bladder Cancer

Advertisement
The UromigosUromigos Live 2024 | September 30, 2024
Listen to the podcast format of the peri-operative therapy in bladder cancer panel from Uromigos Live 2024.
Listen Now
The UromigosUromigos Live 2024 | September 28, 2024
Listen to the podcast format of the panel on on emerging ADC data in bladder cancer from Uromigos Live 2024.
The UromigosUromigos Live and Unplugged | November 11, 2022
Petros Grivas, MD, PhD, Director of UW Medicine's GU Cancers Program, talks about the efficacy of sacituzumab govitecan.
The UromigosUromigos Live and Unplugged | November 11, 2022
Shilpa Gupta, MD discusses maintenance therapy for bladder cancer, including the current standard of care and ongoing trials.
The UromigosUromigos Live and Unplugged | November 11, 2022
Thomas Powles, MBBS, MRCP, MD gives an overview of highlights from The Uromigos: Live & Unplugged bladder cancer session.
The UromigosUromigos Live and Unplugged | November 11, 2022
Matthew Galsky, MD gives insight on adjuvant nivolumab trials, including use in unselected patients and overall survival.
The UromigosUromigos Live and Unplugged | November 15, 2022
Kala Sridhar talks about bladder-sparing treatments for urothelial carcinoma and how patient populations are shifting.
The UromigosUromigos Live and Unplugged | November 11, 2022
Jonathan Rosenberg, MD talks about the development of enfortumab vedotin, including monotherapy info and combination data.
The UromigosUromigos Live and Unplugged | November 10, 2022
The bladder cancer buzzer round from The Uromigos: Live & Unplugged.
Advertisement
Advertisement
Advertisement